Johnson & Johnson’s 1-shot COVID-19 vaccine shows promise in early-stage trials

Johnson & Johnson’s experimental one-shot vaccine for COVID-19 is showing promising results. According to recently published data, the vaccine spurred a long-lasting immune response.